NEO: MMED, OTCQB:MMEDF, DE: BGHM
Revenue (ttm)
Gross Profit (ttm)
Diluted EPS (ttm)
Mr. Stephen L. Hurst
Co-founder, Exec. Chair, Co-CEO & Sec.
Mr. Jamon Alexander Rahn
Co-Founder, Co-CEO & Director
Dr. Miri Halperin Wernli
Pres & Director
Dr. Scott M. Freeman
Co-Founder & Clinical Advisor
Mr. Leonard Latchman
Co-founder
Mr. David Dean Guebert
Chief Financial Officer
Ms. Carol Nast
Chief Operating Officer
Dr. Donald R. Gehlert Ph.D.
Chief Scientific Officer & Member of Scientific Advisory Board
Ms. Madeline Feldman
Director of Operations & Admin.
Mr. Collin Gage
Head of Corp. Devel.
Market Capitalization
$679,348,785
Shares Outstanding
225,697,271
Shares Short (% of Float)
0 (0%)
Insider Ownership
0%